Moffitt Cancer Center & Research Institute Inc.
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Nagi
NCT03598309: Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Recruiting
2
75
US
Curcumin C3 complex®, Curcuminoid, Lovaza®, Omega-3-Acid Ethyl Esters, Placebo, Pill with no drug or other active ingredients in it.
H. Lee Moffitt Cancer Center and Research Institute, James and Esther King Biomedical Research Program
Lung Diseases, Lung Cancer, Protection Against
12/24
12/24
NCT04300855: Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Recruiting
2
135
US
Sunphenon, Green Tea Catechin, Placebo
H. Lee Moffitt Cancer Center and Research Institute, National Cancer Institute (NCI)
Prostate Cancer, Prostate Adenocarcinoma
06/25
06/25
NCT04597359: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Recruiting
2
360
US, RoW
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Sinecatechins, Camellia sinensis Leaf Catechins, Kunecatechins, Polyphenon E, Polyphenon E TM, Veregen
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/32
12/32

Download Options